refametinib (Compound)

Synonyms:Refametinib, 923032-37-5, RDEA119, BAY 869766, RDEA 119, Refametinib [INN], RDEA-119, BAY-869766, (S)-N-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide, JPX07AFM0N, BAY 8697661, Refametinib (RDEA119, Bay 86-9766), N-[3,4-difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide, Refametinib (BAY86-9766), BAY86-9766, BAY-86-9766, BAY-8697661, BAY 86-97661, UNII-JPX07AFM0N, BAY869766, BAY 86-9766, Refametinib (RDEA119), 3e8n, Refametinib; RDEA119, REFAMETINIB [WHO-DD], SCHEMBL345333, GTPL7942, CHEMBL1236682, DTXSID40238961, BDBM520650, EX-A2481, MFCD18633256, NSC800864, s1089, AKOS025401896, BAY8697661, CCG-270103, CS-1818, DB06309, NSC-800864, BAY 86-9766;RDEA119, NCGC00188380-01, NCGC00188380-02, NCGC00188380-03, AC-26962, AS-16994, Cyclopropanesulfonamide, N-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-6-methoxyphenyl)-1-((2S)-2,3-dihydroxypropyl)-, HY-14691, SW218136-2, J3.661.482J, F51934, US11147816, Refametinib (RDEA119, Bay, Q27088526, BAY 869766;BAY 86-97661;RDEA-119;RDEA119, (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide, 923032-36-4, CYCLOPROPANESULFONAMIDE, N-(3,4-DIFLUORO-2-((2-FLUORO-4-IODOPHENYL)AMINO)-6-METHOXYPHENYL)-1-((2S)-2,3-DIHYDROXYPROPYL0-, N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[(2S)-2,3-dihydroxypropyl]cyclopropanesulfonamide, VRA

Pubchem:PUBCHEM:44182295

Id:1965dcd2-91d0-5bb0-b7cd-b653a3ca5059

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View refametinib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for refametinib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with refametinib.

Results found

Linked to

	Label	Description
	BRD-K85751432-001-03-3 Substance (Entity type)	A Substance
	refametinib (28cff25e-c315-4c9f-8c7a-b7bec752056a) Collection (Entity type)	Metadatata for refametinib
	refametinib negatively regulates PHLDA1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	refametinib in similarity relationship with PD-325901 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	refametinib positively regulates MATN2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	refametinib in similarity relationship with binimetinib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	refametinib negatively regulates DKK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	refametinib positively regulates IFIT1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	refametinib positively regulates MX1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	refametinib negatively regulates PLAUR Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS